Skip to main content
Indian stocks: Visit www.stage2stocks.com →

IDEXX Laboratories, Inc.

Stage 4 · Declining · week 7

As of Oct 22, 2026, IDEXX Laboratories is in Stage 4, the downtrend phase, now in week 7 (since Sep 8, 2026). It closed at $566.76, 26.1% below its 52-week high and below its 200-day average, which is falling.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. More about the company

$566.76
+2.40% today
$44.6B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is IDXX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 14w
S4 14w
S4 15w
S2 36w
S4 19w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 5w → S3 2w → S4 9w → S1 4w → S2 14w → S3 9w → S4 14w → S1 4w → S4 15w → S1 8w → S4 5w → S1 2w → S2 36w → S3 6w → S4 19w → S1 4w → S4 6w current
Total tracked: 164 weeks across 17 stage runs.

IDXX among Diagnostics & Research30th of 44 by relative strength

All 44 →
Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CDNAStage 2 · wk 2499+27.3%
2BDSXStage 2 · wk 1898−18.3%
3ILMNStage 2 · wk 2497+5.5%
4GHStage 2 · wk 2197−7.6%
5NTRAStage 2 · wk 2096+2.7%
6CRLStage 2 · wk 1692+22.5%
7RVTYStage 2 · wk 1890+10.7%
8PSNLStage 2 · wk 1790−3.2%
…30IDXXStage 4 · wk 746+8.6%
vs 52W High
-26.1%
$504.70 lo$766.68 hi
26.1% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 7
1w13w26w
Week 7, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-1.8%
200 DMA: $577.16 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.84x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+8.6%
3M
+4.1%
6M
+1.0%
YTD
-15.4%
1Y
-11.0%
Scan Membership
Breakout Watch
Latest: 2025-06-02
8 appearances in last 60 days. First seen: 2019-05-01.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 7 · Vol 0.84x
2026-10-21S4
Wk 7 · Vol 0.73x
2026-10-20S4
Wk 7 · Vol 0.85x
2026-10-19S4
Wk 6 · Vol 0.96x
2026-10-16S4
Wk 6 · Vol 1.37x
2026-10-15S4
Wk 6 · Vol 1.04x
2026-10-14S4
Wk 6 · Vol 1.53x
2026-10-13S4
Wk 6 · Vol 0.80x
2026-10-12S4
Wk 5 · Vol 1.00x
2026-10-09S4
Wk 5 · Vol 0.84x
2026-10-08S4
Wk 5 · Vol 1.26x
2026-10-07S4
Wk 5 · Vol 1.31x
Moving averages & range
50 DMA
$533.14
200 DMA
$577.16
52W High
$766.68
52W Low
$504.70
5D Low
$553.48
Resistance levels (recent highs)
20d High
$566.76
60d High
$595.76
120d High
$595.76
250d High
$766.68
Next resistance
+5.1%
to 60d High
P/E (TTM)
39.8
Forward 33.8
Earnings Growth (YoY)
+17.6%
Revenue +9.7%
ROE
+74.2%
Profit margin +25.0%
Dividend Yield
0.00%
P/B 27.7

IDEXX Laboratories: quick answers

What stage is IDEXX Laboratories in?

As of Oct 22, 2026, IDEXX Laboratories (IDXX) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 8, 2026 and is in week 7. What the four stages mean

Is IDEXX Laboratories in an uptrend?

No. IDEXX Laboratories is in a Stage 4 downtrend. It trades 1.8% below its 200-day average, which is falling.

How far is IDEXX Laboratories from its 52-week high?

IDEXX Laboratories closed at $566.76 on Oct 22, 2026, 26.1% below its 52-week high of $766.68. Its 52-week low is $504.70.

How has IDEXX Laboratories performed over the past year?

As of Oct 22, 2026, IDEXX Laboratories is down 11.0% over the past year and down 15.4% so far in 2026.

Which sector and industry is IDEXX Laboratories in?

IDEXX Laboratories is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.